Relationship between interleukin-1 genotype and peri-implantitis: A literature review

Quintessence International

Volumn 39, Issue 4, 2008, Pages 289-298

  Andreiotelli, Marina ^a,b   Koutayas, Spiridon Oumvertos ^b   Madianos, Phoebus N ^c   Strub, Jörg Rudolf ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b National and Kapodistrian University of Athens ^*  (Germany)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Genotype; Host response; Interleukin 1; Peri implantitis; Susceptibility

Indexed keywords

INTERLEUKIN 1;

CHEMISTRY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; GINGIVITIS; HUMAN; IMMUNOLOGY; PERIODONTITIS; PREDICTION AND FORECASTING; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TOOTH IMPLANTATION;

DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GINGIVAL CREVICULAR FLUID; HUMANS; INTERLEUKIN-1; PERIODONTITIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS;

EID: 40749122142     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Adell R, Eriksson B, Lekholm U, Brånemark P-I, Jemt T. Long-term follow-up study of osseointegrated implants in the treatment of totally edentulous jaws. Int J Oral Maxillofac Implants 1990;5:347-359.
2. Albrektsson T, Dahl E, Enbom L, et al. Osseointegrated oral implants. A Swedish multicenter study of 8139 consecutively inserted Nobel-pharma implants. J Periodontol 1988;59:287-296.
3. Meffert RM, Langer B, Fritz ME. Dental implants: A review. J Periodontol 1992;63:859-870.
4. Buser D, Mericske-Stern R, Bernard JP, et al. Long-term evaluation of non-submerged ITI implants. Part 1: 8-year life table analysis of a prospective multi-center study with 2359 implants. Clin Oral Implants Res 1997;8:161-172.
5. Binon PP. Implants and components: Entering the new millennium. Int J Oral Maxillofac Implants 2000;15:76-94.
6. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. (II). Etiopathogenesis. Eur J Oral Sci 1998;106:721-764.
7. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. (I). Success criteria and epidemiology. Eur J Oral Sci 1998;106:527-551.
8. Tonetti MS, Schmid J. Pathogenesis of implant failures. Periodontol 2000 1994;4:127-138.
9. Mombelli A, Lang NP. The diagnosis and treatment of peri-implantitis. Periodontol 2000 1998;17:63-76.
10. Lekholm U, Adell R, Lindhe J, et al. Marginal tissue reactions at osseointegrated titanium fixtures. (II) A cross-sectional retrospective study. Int J Oral Maxillofac Surg 1986;15:53-61.
11. Lindhe J, Berglundh T, Ericsson I, Liljenberg B, Marinello C. Experimental breakdown of peri-implant and periodontal tissues. A study in the beagle dog. Clin Oral Implants Res 1992;3:9-16.
12. Jovanovic SA, Kenney EB, Carranza FA Jr, Donath K. The regenerative potential of plaque-induced peri-implant bone defects treated by a submerged membrane technique: An experimental study. Int J Oral Maxillofac Implants 1993;8:13-18.
13. Berglundh T, Persson L, Klinge B. A systematic review of the incidence of biological and technical complications in implant dentistry reported in prospective longitudinal studies of at least 5 years. J Clin Periodontol 2002;29:197-212.
14. Brägger U, Aeschlimann S, Burgin W, Hämmerle CHF, Lang NP. Biological and technical complications and failures with fixed partial dentures (FPD) on implants and teeth after four to five years of function. Clin Oral Implants Res 2001;12:26-34.
15. Jansson H, Hamberg K, De Bruyn H, Bratthall G. Clinical consequences of IL-1 genotype on early implant failures in patients under periodontal maintenance. Clin Implant Dent Relat Res 2005;7: 51-59.
16. Wilson TG Jr, Nunn M. The relationship between the interleukin-1 periodontal genotype and implant loss. Initial data. J Periodontol 1999:70:724-729.
17. Ataoglu H, Alptekin NO, Haliloglu S, et al. Interleukin-1 beta, tumor necrosis factor-alpha levels and neutrophil elastase activity in peri-implant crevicular fluid. Clin Oral Implants Res 2002;13: 470-476.
18. Aboyoussef H, Carter C, Jandinski JJ, Panagakos FS. Detection of prostaglandin E2 and matrix metallo-proteinases in implant crevicular fluid. Int J Oral Maxillofac Implants 1998;13:689-696.
19. Murata M, Tatsumi J, Kato Y, et al. Osteocalcin, deoxypyridinoline and interleukin-1 beta in peri-implant crevicular fluid of patients with peri-implantitis.Clin Oral Implants Res 2002;13:637-643.
20. Salcetti JM, Moriarty JD, Cooper LF, et al. The clinical, microbial, and host response characteristics of the failing implant. Int J Oral Maxillofac Implants 1997; 12:32-42.
21. Panagakos FS, Aboyoussef H, Dondero R, Jandinski JJ. Detection and measurement of inflammatory cytokines in implant crevicular fluid: A pilot study, Int J Oral Maxillofac Implants 1996;11:794-799.
22. Kao RT, Curtis DA, Richards DW, Preble J. Increased interleukin-1 beta in the crevicular fluid of diseased implants. Int J Oral Maxillofac Implants 1995;10: 696-701.
23. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodontal Res 1993;28:500-510.
24. Offenbacher S. Periodontal diseases: Pathogenesis. Ann Periodontol 1996;1:821-878.
25. Bascones A, Gamonal J, Gomez M, Silva A, Gonzalez MA. New knowledge of the pathogenesis of periodontal disease.Quintessence Int2004;35:706-716.
26. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 1998;9:248-266.
27. Curtis DA, Kao R, Plesh O, Finzen F, Franz L. Crevicular fluid analysis around two failing dental implants: A clinical report. J Prosthodont 1997;6:210-214.
28. Kornman KS, Crane A, Wang HY, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997;24:72-77.
29. Kornman KS, di Giovine FS. Genetic variations in cytokine expression: A risk factor for severity of adult periodontitis. Ann Periodontol 1998;3: 327-338.
30. Kornman KS. Interleukin-1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging. Am J Clin Nutr 2006; 83:4755-4835.
31. Berglundh T, Lindhe J, Ericsson I, Marinello C, Liljenberg B, Thomsen P. The soft tissue barrier at implants and teeth. Clin Oral Implants Res 1991; 2:81-90.
32. Mombelli A, Mericske-Stern R. Microbiological features of stable osseointegrated implants used as abutments for overdentures. Clin Oral Implants Res 1990;1:1-7.
33. Gruica B, Wang HY, Lang NP, Buser D. Impact of IL-1 genotype and smoking status on the prognosis of osseointegrated implants. Clin Oral Implants Res 2004;15:393-400.
34. Feloutzis A, Lang NP, Tonetti MS, et al. IL-1 gene polymorphism and smoking as risk factors for peri-implant bone loss in a well-maintained population. Clin Oral Implants Res 2003;14:10-17.
35. Rogers MA, Figliomeni L, Baluchova K, et al. Do interleukin-1 polymorphisms predict the development of periodontitis or the success of dental implants? J Periodontal Res 2002;37:37-41.
36. Laine ML, Leonhardt A, Roos-Jansåker AM, et al. IL-1RN gene polymorphism is associated with periimplantitis. Clin Oral Implants Res 2006;17:380-385.
37. Ericsson I, Persson LG, Berglundh T, Edlund T, Lindhe J. The effect of antimicrobial therapy on periimplantitis lesions. An experimental study in the dog. Clin Oral Implants Res 1996;7:320-328.
38. Zitzmann NU, Berglundh T, Ericsson I, Lindhe J. Spontaneous progression of experimentally induced periimplantitis. J Clin Periodontol 2004;31: 845-849.
39. Baron M, Haas R, Dörtbudak O, Watzek G. Experimentally induced peri-implantitis: A review of different treatment methods described in the literature. Int J Oral Maxillofac Implants 2000;15: 533-544.
40. Pontoriero R, Tonetti MS, Carnevale G. Experimentally induced peri-implant mucositis. A clinical study in humans. Clin Oral Implants Res 1994;5:254-259.
41. Berglundh T, Lindhe J, Marinello C, Ericsson I, Liljenberg B. Soft tissue reaction to de novo plaque formation on implants and teeth. An experimental study in the dog. Clin Oral Implants Res 1992;3:1-8.
42. Rutar A, Lang NP, Buser D, Bürgin W, Mombelli A. Retrospective assessment of clinical and microbiological factors affecting periimplant tissue conditions. Clin Oral Implants Res 2001;12:189-195.
43. Sanz M, Aladez J, Lazaro P, Calvo JL, Quirynen M, van Steenberghe D. Histopathologic characteristics of peri-implant soft tissues in Branemark implants with 2 distinct clinical and radiological patterns. Clin Oral Implants Res 1991;2:128-134.
44. Piattelli A, Scarano A, Piattelli M. Histologie observations on 230 retrieved dental implants: 8 years' experience (1989-1996). J Periodontol 1998;69: 178-184.
45. Tatakis DN. Interleukin-1 and bone metabolism: A review. J Periodontol 1993;64:416-431.
46. van der Zee E, Everts V, Beertsen W. Cytokines modulate routes of collagen breakdown. Review with special emphasis on mechanisms of collagen degradation in the periodontium and the burst hypothesis of periodontal disease progression. J Clin Periodontol 1997;24:297-305.
47. Takashiba S, Naruishi K, Murayama Y. Perspective of cytokine regulation for periodontal treatment: Fibroblast biology. J Periodontol 2003;74:103-110.
48. Hultin M, Gustafsson A, Hallström H, Johansson LA, Ekfeldt A, Klinge B. Microbiological findings and host response in patients with peri-implantitis. Clin Oral Implants Res 2002;13:349-358.
49. Gualini F, Berglundh T. Immunohistochemical characteristics of inflammatory lesions at implants. J Clin Periodontol 2003;30:14-18.
50. Lang NP, Brägger U, Walther D, Beamer B, Kornman KS. Ligature-induced peri-implant infection in cynomolgus monkeys. I. Clinical and radiographic findings. Clin Oral Implants Res 1993;4:2-11.
51. Marinello CP, Berglundh T, Ericsson I, Klinge B, Glantz PO, Lindhe J. Resolution of ligature-induced peri-implantitis lesions in the dog. J Clin Periodontol 1995;22:475-479.
52. Berglundh T, Gislason O, Lekholm U, Sennerby L, Lindhe J. Histopathological observations of human periimplantitis lesions. J Clin Periodontol 2004;31: 341-347.
53. Bain CA, Moy PK. The association between the failure of dental implants and cigarette smoking. Int J Oral Maxillofac Implants 1993;8:609-615.
54. Wallace RH. The relationship between cigarette smoking and dental implant failure. Eur J Prosthodont Restor Dent 2000;8:103-106.
55. Olson JW, Shernoff AF, Tarlow JL, Colwell JA, Scheetz JP, Bingham SF. Dental endosseous implant assessments in a type 2 diabetic population: A prospective study. Int J Oral Maxillofac Implants 2000;15:811-818.
56. Fiorellini JP, Chen PK, Nevins M, Nevins ML. A retrospective study of dental implants in diabetic patients. Int J Periodontics Restorative Dent 2000; 20:366-373.
57. Siervo S, Wirz J, Schmidli F, Coraini C, Siervo P. Late implant failures and genetic susceptibility: Links and hints [abstract]. J Clin Periodontol 2000;27:78.
58. Mombelli A, Lang NP. Clinical parameters for the evaluation of dental implants. Periodontol 2000 1994;4:81-86.
59. Lang NP, Wilson TG, Corbet EF. Biological complications with dental implants: Their prevention, diagnosis and treatment. Clin Oral Implants Res 2000; 11:146-155.
60. Adell R, Lekholm U, Rockier B, Br anemark PI. A 15-year study of osseointegrated implants in the treatment of the edentulous jaw. Int J Oral Surg 1981;10: 387-416.
61. Lang NP, Joss A, Orsanic T, Gusberti FA, Siegrist BE. Bleeding on probing. A predictor for the progression of periodontal disease? J Clin Periodontol 1986;13:590-596.
62. Luterbacher S, Mayfield L, Brägger U, Lang NP. Diagnostic characteristics of clinical and microbiological tests for monitoring periodontal and periimplant mucosal tissue conditions during supportive periodontal therapy (SPT). Clin Oral Implants Res 2000;11:521-529.
63. Albrektsson T, Zarb G, Worthington P, Eriksson AR. The long-term efficacy of currently used dental implants: A review and proposed criteria of success, Int J Oral Maxillofac Implants 1986;1:11-25.
64. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003;74:391-401.
65. Konttinen YT, Ma J, Lappalainen R, Laine P, Kitti U, Santavirta S, Teronen O. Immunohistochemical evaluation of inflammatory mediators in failing implants. Int J Periodontics Restorative Dent 2006;26:135-141.
66. Stashenko P, Fujiyoshi P, Obernesser MS, Prostak L, Haffajee AD, Socransky SS. Levels of interleukin 1 beta in tissue from sites of active periodontal disease. J Clin Periodontol 1991;18:548-554.
67. Masada MP, Persson R, Kenney JS, Lee SW, Page RC, Allison AC. Measurement of interleukin-1 alpha and -1 beta in gingival crevicular fluid: Implications for the pathogenesis of periodontal disease. J Periodontal Res 1990;25:156-163.
68. Figueredo CM, Ribeiro MS, Fischer RG, Gustafsson A. Increased interleukin-1 beta concentration in gingival crevicular fluid as a characteristic of periodontitis. J Periodontol 1999;70:1457-1463.
69. +3954 genotype. A cross-sectional study on implant recall patients with and without clinical signs of peri-implantitis. Clin Oral Implants Res 2007;18:212-223.
70. Hultin M, Gustafsson A, Hallström H, Johansson LA, Ekfeldt A, Klinge B. Microbiological findings and host response in patients with peri-implantitis. Clin Oral Implants Res 2002;13:349-358.
71. Michalowicz BS, Diehl SR, Gunsolley JC, et al. Evidence of a substantial genetic basis for risk of adult periodontitis. J Periodontol 2000;71:1699-1707.
72. Nicklin MJH, Weith A, Duff GW. A physical map of the region encompassing the human interleukin 1 alpha, beta and the interleukin-1 receptor antagonist genes. Genomics 1994;19:382-384.
73. Kinane DF, Shiba H, Hart TC. The genetic basis of periodontitis. Periodontol 2000 2005;39:91-117.
74. Kinane DF, Hart TC. Genes and gene polymorphisms associated with periodontal disease. Crit Rev Oral Biol Med 2003;14:430-449.
75. Nares S. The genetic relationship to periodontal disease. Periodontol 2000 2003;32:36-49.
76. Greenstein G, Hart TC. A critical assessment of interleukin-1 (IL-1) genotyping when used in a genetic susceptibility test for severe chronic periodontitis. J Periodontol 2002;73:231-247.
77. Greenstein G, Hart TC. Clinical utility of a genetic susceptibility test for severe chronic periodontitis: A critical evaluation. J Am Dent Assoc 2002;133:452-459.
78. Armitage GC, Wu Y, Wang HY, Sorrell J, di Giovine FS, Duff GW. Low prevalence of a periodontitis-associated interleukin-1 composite genotype in individuals of Chinese heritage. J Periodontol 2000;71:164-171.
79. Salonen MA, Oikarinen K, Virtanen K, Pernu H. Failures in the osseointegration of endosseous implants. Int J Oral Maxillofac Implants 1993;8:92-97.
80. Teixeira ER, Sato Y, Akagawa Y, Kimoto T. Correlation between mucosal inflammation and marginal bone loss around hydroxyapatite-coated implants: A 3-year cross-sectional study. Int J Oral Maxillofac Implants 1997;12:74-81.
81. Klokkevold PR, Newman MG. Current status of dental implants: A periodontal perspective. Int J Oral Maxillofac Implants 2000;15:56-65.
82. Leonhardt A, Berglundh T, Ericsson I, Dahlén G. Putative periodontal pathogens on titanium implants and teeth in experimental gingivitis and periodontitis in beagle dogs. Clin Oral Implants Res 1992;3:112-119.
83. Quirynen M, De Soete M, van Steenberghe D. Infectious risks for oral implants: A review of the literature. Clin Oral Implants Res 2002;13:1-19.
84. Sánchez-Garcés MÁ, Gay-Escoda C. Periimplantitis. Med Oral Patol Oral Cir Bucal 2004;9(suppl):69-74; 63-69.
85. De Smet E, van Steenberghe D, Quirynen M, Naert I. The influence of plaque and/or excessive loading on marginal soft and hard tissue reactions around Branemark implants: A review of literature and experience. Int J Periodontics Restorative Dent 2001;21:381-393.
86. Michalowicz BS, Aeppli D, Virag JG, et al. Periodontal findings in adult twins. J Periodontol 1991;62:293-299.
87. Michalowicz BS. Genetic and heritable risk factors in periodontal disease. J Periodontol 1994;65:479-488.
88. De Bruyn H, Collaert B. The effect of smoking on early implant failure. Clin Oral Implants Res 1994;5:260-264.